Kemps-Polanco Reshema has filed 8 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 946 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ($CRL) on May 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Common Stock | 946 | $134.98 | 1,960.0000 | 51,201,000 | 93.29% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Common Stock | 630 | $134.98 | 2,590.0000 | 51,201,000 | 32.14% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Stock Options (Right to Buy) | 2076 | $134.98 | 2,076.0000 | 51,201,000 | 9999.99% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Common Stock | 559 | $228.41 | 729.0000 | 51,552,000 | 328.82% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Common Stock | 285 | $228.41 | 1,014.0000 | 51,552,000 | 39.09% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Stock Options (Right to Buy) | 1311 | $228.41 | 1,311.0000 | 51,552,000 | 9999.99% | 0.00% |
| Feb. 1, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Common Stock | 170 | $0.00 | 170.0000 | 51,338,000 | 9999.99% | 0.00% |
| Feb. 1, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Kemps-Polanco Reshema | Director | A | Stock Options (Right to Buy) | 399 | $219.54 | 399.0000 | 51,338,000 | 9999.99% | 0.00% |